METTL3 facilitates m6A modification of suppressor of cytokine signaling 2 (SOCS2) and promotes its mRNA degradation through a YTHDF2-dependent pathway, thereby regulating the progression of liver cancer (Chen et al. 2018). The gene discussed is SOCS2; the disease is liver cancer.